Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
MWG Management Ltd. (CIK 1845151) reported $81.3M across 3 reported positions in its SEC 13F filing for 2025-09-30. Largest positions: BEAM ($55.0M, 67.66%), LYEL ($16.4M, 20.13%), PRME ($9.9M, 12.21%), LYEL ($0, 0.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | BEAM | BEAM THERAPEUTICS INC | $55.0M | 67.66% | 2.3M | Hold |
| 2 | LYEL | LYELL IMMUNOPHARMA INC | $16.4M | 20.13% | 1.0M | New |
| 3 | PRME | PRIME MEDICINE INC | $9.9M | 12.21% | 1.8M | Hold |
| 4 | LYEL | LYELL IMMUNOPHARMA INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2025-09-30